Taxanes in primary systemic treatment of breast cancer

被引：5
|
作者：
von Minckwitz, G [1 ]
机构：
[1] German Breast Grp, Frankfurt, Germany
来源：
ONKOLOGIE | 2003年 / 26卷
关键词：
primary systemic therapy; breast cancer; docetaxel;
D O I：
10.1159/000076170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Primary systemic treatment today represents a new option for patients with operable breast cancer and is equally effective as conventional adjuvant chemotherapy. Improving surgical options is the most important indication for choosing this approach. The highest chance for breast conserving surgery can be obtained when a sequence of adriamycin and cyclophosphamide (AC) is followed by docetaxel. This has been shown in the Geparduo and NSABP-B27 trial. New approaches are considering individual tailoring of treatment according to either early response of the primary breast tumor (Gepartrio) or pharmacogenetic testing on the tumor tissue.
引用
收藏
页码：21 / 25
页数：5
相关论文
共 50 条
  • [21] Efficacy of primary systemic chemotherapy regimen containing anthracyclines with/without taxanes in comparison to CMF in women with early breast cancer
    Gschwantler-Kaulich, D.
    Fink-Retter, A.
    Hudelist, G.
    Bachrich, T.
    Ledesma, M.
    Ruecklinger, E.
    Kubista, E.
    Singer, C. F.
    [J]. JOURNAL OF CHEMOTHERAPY, 2007, 19 (06) : 731 - 738
  • [22] Efficacy of primary systemic chemotherapy regimen containing anthracyclines with/without taxanes in comparison to CMF in women with early breast cancer
    Gschwantler-Kaulich, D.
    Fink-Retter, A.
    Bachrich, T.
    Ledesma, M.
    Ruecklinger, E.
    Kubista, E.
    Singer, C. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] The Role of Taxanes in the Adjuvant Treatment of Early Stage Breast Cancer
    Martine Piccart
    [J]. Breast Cancer Research and Treatment, 2003, 79 (Suppl 1) : 25 - 34
  • [24] Adjuvant taxanes in the treatment of breast cancer: No longer at the tip of the iceberg
    Dang, Chau
    [J]. CLINICAL BREAST CANCER, 2006, 7 (01) : 51 - 58
  • [25] Activity of Ixabepilone in Patients with Metastatic Breast Cancer with Primary Resistance to Taxanes
    Yardley, Denise A.
    [J]. CLINICAL BREAST CANCER, 2008, 8 (06) : 487 - 492
  • [26] Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
    Edgardo Rivera
    Mary Cianfrocca
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 659 - 670
  • [27] The taxanes: Miracles for breast cancer treatment or just more chemotherapy?
    Claringbold, PG
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1997, 166 (10) : 518 - 519
  • [28] Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment
    Vici, P.
    Viola, G.
    Rossi, S.
    Botti, C.
    Vitucci, C.
    Sergi, D.
    Ferranti, F. R.
    Saracca, E.
    Di Lauro, L.
    Corsetti, S.
    Foggi, P.
    Fattoruso, S. I. S.
    Lopez, M.
    [J]. CLINICA TERAPEUTICA, 2008, 159 (06): : 453 - 456
  • [29] Introducing taxanes in the adjuvant treatment of breast cancer: expectations and reality
    Colleoni, M
    Orlando, L
    Nole, F
    Goldhirsch, A
    [J]. BREAST, 2000, 9 (03): : 134 - 138
  • [30] Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
    Rivera, Edgardo
    Cianfrocca, Mary
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 659 - 670
12345